Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: The tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study-Reference-Cited by-同舟云学术

Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: The tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study

Published:2008-10 Issue:10 Volume:58 Page:2968-2980
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Genovese Mark C.,McKay James D.,Nasonov Evgeny L.,Mysler Eduardo F.,da Silva Nilzio A.,Alecock Emma,Woodworth Thasia,Gomez-Reino Juan J.

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference40 articles.

1. Cytokine pathways and joint inflammation in rheumatoid arthritis;Choy;N Engl J Med,2001

2. Patient perspective: reasons and methods for measuring fatigue in rheumatoid arthritis;Kirwan;J Rheumatol,2007

3. Treatment of rheumatoid arthritis;Gaffo;Am J Health Syst Pharm,2006

4. New therapies for treatment of rheumatoid arthritis;Smolen;Lancet,2007

5. New drugs for rheumatoid arthritis;Olsen;N Engl J Med,2004

Cited by 719 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. scBlood: A comprehensive single-cell accessible chromatin database of blood cells;Computational and Structural Biotechnology Journal;2024-12

2. Synthesis and characterization of Bi2S3@NH2-MIL125(Ti) and survey the sono-catalytic ozonation process’s efficiency in the degradation of tocilizumab from aqueous;Inorganic Chemistry Communications;2024-11

3. Effectiveness of Exercise Intervention in Preventing Active Arthritis Exacerbation in an SKG Mouse Model of Rheumatoid Arthritis;2024-08-25

4. Validation of an Analytical Procedure for Evaluating the Biological Activity of a Medicinal Product Based on Tocilizumab and Determination of Acceptance Criteria for Test Results;Regulatory Research and Medicine Evaluation;2024-06-19

5. Designing target trials using electronic health records: A case study of second-line disease-modifying anti-rheumatic drugs and cardiovascular disease outcomes in patients with rheumatoid arthritis;PLOS ONE;2024-06-14